Australian Clinical Labs Ltd (AU:ACL) has released an update.
Mitsubishi UFJ Financial Group, Inc. has acquired a 5.01% stake in Australian Clinical Labs Limited, marking its position as a substantial holder in the company. This significant move, documented in the Form 603 under the Corporations Act 2001, was announced after the group obtained voting power over a substantial number of fully paid ordinary shares. The financial group’s relevant interest spans several tranches of shares, with a considerable influence in both Morgan Stanley and First Sentier Investors Holdings Pty Limited as detailed in the notice.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
